{"ORPHApacket":[{"ORPHApacketID":"86875","date":"2019-12-05 19:07:51","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"86875","Name":[{"lang":"en","label":"Adult T-cell leukemia\/lymphoma"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_86875","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Aggressive primary cutaneous T-cell lymphoma"}],"ORPHA":"178551","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_178551"},{"Name":[{"lang":"en","label":"Rare virus associated tumor"}],"ORPHA":"289635","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_289635"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare, virus associated tumor due to human T-cell leukemia virus type 1 or human T-cell lymphotropic virus type 1 (HTLV-1) and is characterized by the presence of anti-HTLV-1 antibodies, and malignant, mature, medium-sized T cells with condensed chromatin and polylobated nuclei. The malignant cells exhibit a mature CD4+ T cells phenotype and express CD2, CD5, CD25, CD45RO, HLA-DR, and T-cell receptor &#945;&#946;. Presentation is heterogeneous and is typically of aggressive leukemia or lymphoma, variable skin eruptions, and visceral organ involvement."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]}]}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Multigenic\/multifactorial"}]},{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"ATLL"}]}]}]}